Langerhans cell-targeted mRNA delivery: A strategy for dose-sparing and enhanced antitumor immunity. Klein K, Johnson L, Rica R, Sarcevic M, et al. J Invest Dermatol 2026;146:2793-2801.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Klein K, Johnson L, Rica R, Sarcevic M, et al. Langerhans cell-targeted mRNA delivery: A strategy for dose-sparing and enhanced antitumor immunity. J Invest Dermatol 2026;146:2793-2801.
PMID: 41956398